Lumos Diagnostics Holdings Limited (LDXHF)
USD 0.02
(0.0%)
USD 0.02
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -7.12 Million USD | 50.29% |
| 2023 | -10.07 Million USD | 53.13% |
| 2022 | -21.49 Million USD | -94.11% |
| 2021 | -11.07 Million USD | -3.53% |
| 2020 | -10.69 Million USD | -263.27% |
| 2019 | -2.94 Million USD | -118.39% |
| 2018 | -1.34 Million USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 FY | -7.78 Million USD | 22.68% |
| 2024 Q1 | -2.81 Million USD | 27.49% |
| 2024 Q2 | -5.87 Million USD | -108.68% |
| 2024 Q3 | -354 Thousand USD | 93.97% |
| 2024 Q4 | -354 Thousand USD | 0.0% |
| 2023 Q4 | -3.88 Million USD | -101.52% |
| 2023 FY | -10.07 Million USD | 53.13% |
| 2023 Q3 | -1.92 Million USD | 69.93% |
| 2023 Q2 | -6.4 Million USD | -120.28% |
| 2023 Q1 | -2.9 Million USD | 77.51% |
| 2022 Q4 | -12.92 Million USD | 0.0% |
| 2022 FY | -21.49 Million USD | -94.11% |
| 2022 Q2 | -10.78 Million USD | 0.0% |
| 2021 Q4 | -8.41 Million USD | 0.0% |
| 2021 Q2 | -2.78 Million USD | 0.0% |
| 2021 FY | -11.07 Million USD | -3.53% |
| 2020 Q2 | -3.9 Million USD | 0.0% |
| 2020 Q4 | -6.86 Million USD | 0.0% |
| 2020 FY | -10.69 Million USD | -263.27% |
| 2019 FY | -2.94 Million USD | -118.39% |
| 2018 FY | -1.34 Million USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| American Bio Medica Corporation | -1.24 Million USD | -473.43% |
| Arrayit Corporation | -3.62 Million USD | -96.604% |
| Atlantic International Corp. | -5.73 Million USD | -24.239% |
| Biocept, Inc. | -31.98 Million USD | 77.732% |
| Bioqual, Inc. | -19.63 Thousand USD | -36166.422% |
| CardioGenics Holdings Inc | -772.14 Thousand USD | -822.369% |
| DermTech, Inc. | -103.73 Million USD | 93.135% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.48 Billion USD | 100.286% |
| HTG Molecular Diagnostics, Inc. | -20.82 Million USD | 65.808% |
| iMD Companies, Inc. | -175.44 Thousand USD | -3959.369% |
| IDenta Corp. | -1499.00 USD | -475016.744% |
| Interpace Biosciences, Inc. | 2.8 Million USD | 353.994% |
| Integrative Health Technologies, Inc. | 38.69 Thousand USD | 18507.857% |
| InVitro International | -25.33 Thousand USD | -28006.871% |
| Many Bright Ideas Technologies Inc. | -58.11 Thousand USD | -12155.644% |
| Medical Imaging Corp. | -819.48 Thousand USD | -769.088% |
| NovelStem International Corp. | -3.52 Million USD | -101.997% |
| Optigenex Inc. | 1.39 Million USD | 612.066% |
| PharmChem, Inc. | 973.14 Thousand USD | 831.852% |
| Proteome Sciences plc | -1.62 Million USD | -339.358% |
| Response Genetics, Inc | -21.37 Million USD | 66.684% |
| Rennova Health, Inc. | -1.4 Million USD | -405.273% |
| RushNet, Inc. | -684.7 Thousand USD | -940.156% |
| ScreenPro Security Inc. | -2.59 Million USD | -174.723% |
| Stella Diagnostics Inc. | -11.42 Million USD | 37.674% |
| StageZero Life Sciences Ltd. | -7.74 Million USD | 8.065% |
| Todos Medical Ltd. | -9.74 Million USD | 26.939% |